Related Experiment Video

Updated: Aug 19, 2026

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
03:57

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Published on: July 14, 2023

[Genetics in secondary hyperparathyroidism of uremia]

Tahara Hideki1

  • 1Division of Metabolism, Endocrinology, and Molecular Medicine, Department of Internal Medicine Osaka City University Graduate School of Medicine.

Clinical Calcium
|March 19, 2005
PubMed

Insights

Genetic alterations in uremic hyperparathyroidism are largely unknown. This study investigates specific oncogenes and tumor suppressor genes, alongside candidate gene polymorphisms, in the pathogenesis of this condition.

Area of Science:

  • Endocrinology
  • Genetics
  • Oncology

Context:

  • Uremic hyperparathyroidism is a common complication in patients with chronic kidney disease.
  • The genetic basis of parathyroid hyperplasia in uremia remains poorly understood.
  • Existing knowledge on common parathyroid adenomas (e.g., cyclin D1 overexpression, MEN1 inactivation) may not directly apply to uremic cases.

Purpose:

  • To identify specific oncogenes or tumor suppressor genes involved in the development of monoclonal uremic hyperparathyroidism.
  • To explore the role of candidate gene polymorphisms in the pathogenesis of uremic hyperparathyroidism.
  • To advance the understanding of the molecular mechanisms underlying parathyroid hyperplasia in the context of chronic kidney disease.

Summary:

  • Genetic alterations driving parathyroid hyperplasia in uremic patients are largely unidentified.
  • While cyclin D1 overexpression and MEN1 gene inactivation are observed in some common parathyroid adenomas, their role in uremic hyperparathyroidism is unclear.
  • Research suggests that specific genetic polymorphisms may contribute to the development of this condition.

Impact:

  • This research aims to uncover key genetic factors in uremic hyperparathyroidism, potentially leading to novel diagnostic markers or therapeutic targets.
  • Improved understanding of the genetic landscape can inform personalized treatment strategies for patients with chronic kidney disease and secondary hyperparathyroidism.
  • Findings could elucidate the distinct molecular pathways differentiating uremic parathyroid hyperplasia from common parathyroid adenomas.

More Related Videos

Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation07:13

Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation

Published on: March 14, 2017

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring07:35

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring

Published on: June 23, 2015

Related Concept Videos

The Parathyroid Glands00:59

The Parathyroid Glands

The two pairs of parathyroid glands embedded within the posterior surface of the thyroid gland are restricted by a dense capsule around them. These glands comprise two distinct cell populations—parathyroid oxyphil and parathyroid principal cells- pivotal in calcium homeostasis.
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Physiology of the Genitourinary System II: Tubular Reabsorption and Secretion01:22

Physiology of the Genitourinary System II: Tubular Reabsorption and Secretion

The kidneys maintain homeostasis through filtration, reabsorption, and secretion. Tubular reabsorption and secretion are crucial in forming urine and regulating electrolytes, water balance, and waste elimination.Tubular Reabsorption and Secretion ProcessesTubular reabsorption is the process that reclaims essential substances such as electrolytes, glucose, amino acids, and water from the glomerular filtrate back into the bloodstream. This is achieved through passive and active transport...
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations01:26

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...